Fulton chose to focus on the development of drug products , medical devices and food supplements for third parties, driven by the vision of supporting innovation and accessibility in the global healthcare industry. This decision arises from the company’s deep technical expertise and broad experience, enabling Fulton to contribute significantly to the development and production of high-quality products. 

By partnering with both small pharmaceutical and multinational companies operating in the global market, Fulton aims to accelerate the time to market of innovative treatments and medical devices for people’s well-being, while ensuring that these products are brought to market to the highest standards of quality and compliance. 

Choosing to operate as a CDMO/CMO in the production of pharmaceuticals, dietary supplements and medical devices is therefore a natural alignment with Fulton’s mission to serve the health and well-being of people on a global scale, by providing tangible added value to the pharmaceutical and medical supply chain.